These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7505277

  • 1. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA, Wright JA.
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [Abstract] [Full Text] [Related]

  • 2. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA, Wright JA.
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [Abstract] [Full Text] [Related]

  • 3. Malignant transformation by H-ras results in aberrant regulation of ribonucleotide reductase gene expression by transforming growth factor-beta 1.
    Hurta RA, Wright JA.
    J Cell Biochem; 1995 Mar; 57(3):543-56. PubMed ID: 7768988
    [Abstract] [Full Text] [Related]

  • 4. Transforming growth factor-beta 1 mediated alterations in ribonucleotide reductase gene expression in BALB/c 3T3 fibroblasts.
    Hurta RA, Greenberg AH, Wright JA.
    J Cell Physiol; 1992 Sep; 152(3):529-35. PubMed ID: 1506411
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J, Hurta RA.
    Biochem Cell Biol; 2000 Sep; 78(4):527-35. PubMed ID: 11012093
    [Abstract] [Full Text] [Related]

  • 6. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D, Mader R, Lee J, Hurta RA.
    Biochem Cell Biol; 2001 Sep; 79(1):69-81. PubMed ID: 11235918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H, Villegas C, Huang A, Wright JA.
    Cancer Res; 1996 Oct 01; 56(19):4366-9. PubMed ID: 8813126
    [Abstract] [Full Text] [Related]

  • 10. Norepinephrine specifically stimulates ribonucleotide reductase subunit R2 gene expression in proliferating brown adipocytes: mediation via a cAMP/PKA pathway involving Src and Erk1/2 kinases.
    Fredriksson JM, Nedergaard J.
    Exp Cell Res; 2002 Apr 01; 274(2):207-15. PubMed ID: 11900481
    [Abstract] [Full Text] [Related]

  • 11. Opposite effects of cyclic AMP on the expression of the genes encoding ribonucleotide reductase in Swiss 3T3 and RAT 1 cells.
    Albert DA, Rozengurt E.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):642-9. PubMed ID: 7694574
    [Abstract] [Full Text] [Related]

  • 12. Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells.
    Amara FM, Hurta RA, Huang A, Wright JA.
    Cancer Res; 1995 Oct 15; 55(20):4503-6. PubMed ID: 7553616
    [Abstract] [Full Text] [Related]

  • 13. S-Adenosylmethionine decarboxylase gene expression is regulated by the cAMP signal transduction pathway in H-ras transformed fibrosarcoma cells capable of malignant progression.
    Hurta RA.
    J Cell Biochem Suppl; 2001 Oct 15; Suppl 36():209-21. PubMed ID: 11455586
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated ribonucleotide reductase R1 gene therapy of human colon adenocarcinoma.
    Cao MY, Lee Y, Feng NP, Xiong K, Jin H, Wang M, Vassilakos A, Viau S, Wright JA, Young AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4553-61. PubMed ID: 14555530
    [Abstract] [Full Text] [Related]

  • 15. Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells.
    Albert DA, Nodzenski E, Yim G, Kowalski J.
    J Cell Physiol; 1990 May 01; 143(2):251-6. PubMed ID: 2159014
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
    Matsunaga T, Gohda E, Takebe T, Wu YL, Iwao M, Kataoka H, Yamamoto I.
    Exp Cell Res; 1994 Feb 01; 210(2):326-35. PubMed ID: 7507855
    [Abstract] [Full Text] [Related]

  • 18. Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations.
    Choy BK, McClarty GA, Chan AK, Thelander L, Wright JA.
    Cancer Res; 1988 Apr 15; 48(8):2029-35. PubMed ID: 2832057
    [Abstract] [Full Text] [Related]

  • 19. Human R1 subunit of ribonucleotide reductase (RRM1): 5' flanking region of the gene.
    Parker NJ, Begley CG, Fox RM.
    Genomics; 1994 Jan 01; 19(1):91-6. PubMed ID: 8188248
    [Abstract] [Full Text] [Related]

  • 20. Multiple synergistic signal transduction pathways regulate c-fos expression in Swiss 3T3 cells: the role of cyclic AMP.
    Mehmet H, Morris C, Rozengurt E.
    Cell Growth Differ; 1990 Jun 01; 1(6):293-8. PubMed ID: 1703775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.